AHA Reviews Impact of Aggressive LDL Lowering on the Brain
The preponderance of evidence does not support the conclusion that aggressive cholesterol-lowering is associated with cognitive impairment or hemorrhagic stroke, a new statement concludes.
Stay updated with breaking news from Ipid Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The preponderance of evidence does not support the conclusion that aggressive cholesterol-lowering is associated with cognitive impairment or hemorrhagic stroke, a new statement concludes.
There is a need to provide practical recommendations for pediatricians regarding the use of low-carbohydrate diets in patients who elect to follow these diets.
Oral muvalaplin lowered lipoprotein(a) in a phase 1 study, and injectable olpasiran did so in an extension of a phase 2 study, both with no adverse safety signals, researchers report.
Many fish oil supplements have labels that make unsubstantiated health claims and include variable daily doses of EPA plus DHA. Researchers call for more regulation.
The antibiotic acts on not one but three molecules that are essential to the construction of bacterial walls.